Form 4: Director Stephen Plavin Receives CWK Equity Grant
Statement of Changes in Beneficial Ownership
Cushman & Wakefield director Stephen Plavin was granted 21,841 restricted stock units as part of the company's 2026 incentive plan.
Summary
- Director Stephen D. Plavin received a grant of 21,841 restricted stock units (RSUs) on May 14, 2026.
- The grant was issued under the Cushman & Wakefield Ltd. 2026 Omnibus Share and Cash Incentive Plan.
- The RSUs convert into common shares on a one-for-one basis at no cost to the director.
- The units are scheduled to vest and settle on May 14, 2027, contingent upon continued board service.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant market-moving implications.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- The grant results in minor potential future dilution for existing shareholders upon vesting.
Risks
- Vesting is subject to the reporting person's continued service on the board of directors.
Future Outlook
The RSUs are expected to vest on May 14, 2027, provided the director remains in service.
Industry Context
StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure directors maintain a vested interest in the company's long-term performance, consistent with industry standards for large-cap real estate services firms.
Comparison to Industry Standards
- The use of RSU grants for director compensation is consistent with practices at peers such as CBRE Group and JLL.
- The one-year vesting schedule is a standard retention mechanism for board members in the professional services sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of RSUs under the 2026 Omnibus Share and Cash Incentive Plan. | 05/14/2026 | Standard alignment of director compensation with company performance. |
Stakeholder Impact
- Minor dilution impact on existing shareholders upon the eventual settlement of the RSUs.
Next Steps
- Vesting of the 21,841 RSUs on May 14, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of RSU grant and earliest transaction. |
| 05/14/2027 | Vesting and settlement date for the granted RSUs. |
| 05/18/2026 | Date of filing. |
Keywords
Cushman & Wakefield, CWK, Form 4, Insider Transaction, Equity Compensation, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.